Y-mAbs is a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. 

Biotechnology

Y-mAbs Therapeutics

Thomas Gad

Karen Tornøe

Johannes Nagel

John Lapolla

Ramin T.

Mallika Vadlamudi, Ph.D.

Linlin Wang

Kandarp Jani

Charlotte A. Russell

Peter Pfreundschuh

Robert Gunning

Courtney Dugan

Tore Søderblom

Sune Nyland

Søren Christensen

Rikke Lillesø

René Christensen

Christopher Naylor

Vignesh Rajah

Joris Wilms

Sue Smith

Scientific Research and Development

Leadership Team

Sales and Account Management

Clinical and Medical Operations

Marketing and Commercial Strategy

Finance and Accounting

Regulatory Affairs and Compliance

Teams at Y-mAbs Therapeutics

Scientific Research and Development

Leadership Team

Sales and Account Management

Clinical and Medical Operations

Marketing and Commercial Strategy

Finance and Accounting

Regulatory Affairs and Compliance